Literature DB >> 1352774

Anion-proton cotransport through the human red blood cell band 3 protein. Role of glutamate 681.

M L Jennings1, J S Smith.   

Abstract

The band 3 protein of the human red blood cell membrane contains a glutamate residue that must be protonated in order for divalent (SO4=) anion transport to take place at an appreciable rate. The carboxyl side chain on this glutamate residue can be converted to the primary alcohol by treatment of intact cells with Woodward's reagent K (N-ethyl-5-phenylisoxazolium 3'-sulfonate) followed by reductive cleavage with BH4-. Edman degradation of CNBr fragments from band 3 labeled in intact cells with Woodward's reagent K and [3H]BH4- showed that Glu681 is heavily labeled under conditions in which Cl- exchange is inhibited, SO4= exchange is accelerated, and Cl- conductance is accelerated. No other glutamate residue in band 3 is detectably labeled under the conditions of these experiments, as demonstrated either by Edman degradation or by the lack of label in major known proteolytic fragments. It is concluded that Glu681 is the binding site for the H+ that is transported with SO4= during band 3-catalyzed H+/SO4= cotransport. This residue is conserved among all species of red cell band 3 (AE1) as well as the related proteins AE2 and AE3. Glu681 is the first amino acid residue in band 3 which has been identified as a binding site for a transported substrate (H+). The functional characteristics of this residue suggest that it lies within the transport pathway and can be alternately exposed to the intracellular and extracellular media.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352774

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Molecular mechanisms of electrogenic sodium bicarbonate cotransport: structural and equilibrium thermodynamic considerations.

Authors:  I Kurtz; D Petrasek; S Tatishchev
Journal:  J Membr Biol       Date:  2004-01-15       Impact factor: 1.843

2.  Solute carriers keep on rockin'.

Authors:  Reinhart A F Reithmeier; Trevor F Moraes
Journal:  Nat Struct Mol Biol       Date:  2015-10       Impact factor: 15.369

3.  Evidence for a second binding/transport site for chloride in erythrocyte anion transporter AE1 modified at glutamate 681.

Authors:  Michael L Jennings
Journal:  Biophys J       Date:  2005-01-14       Impact factor: 4.033

4.  The electrogenicity of the rat sodium-bicarbonate cotransporter NBCe1 requires interactions among transmembrane segments of the transporter.

Authors:  Inyeong Choi; Han Soo Yang; Walter F Boron
Journal:  J Physiol       Date:  2006-10-12       Impact factor: 5.182

5.  Electrodiffusion, barrier, and gating analysis of DIDS-insensitive chloride conductance in human red blood cells treated with valinomycin or gramicidin.

Authors:  J C Freedman; T S Novak
Journal:  J Gen Physiol       Date:  1997-02       Impact factor: 4.086

6.  A substrate access tunnel in the cytosolic domain is not an essential feature of the solute carrier 4 (SLC4) family of bicarbonate transporters.

Authors:  Volodymyr Shnitsar; Jing Li; Xuyao Li; Charles Calmettes; Arghya Basu; Joseph R Casey; Trevor F Moraes; Reinhart A F Reithmeier
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

7.  The role of band 3 protein in oxygen delivery by red blood cells.

Authors:  N Hamasaki
Journal:  Indian J Clin Biochem       Date:  1999-01

Review 8.  The divergence, actions, roles, and relatives of sodium-coupled bicarbonate transporters.

Authors:  Mark D Parker; Walter F Boron
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

9.  Structure of Bor1 supports an elevator transport mechanism for SLC4 anion exchangers.

Authors:  Bryan H Thurtle-Schmidt; Robert M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

10.  Lysine-691 of the anion exchanger from human erythrocytes is located on its cytoplasmic surface.

Authors:  H K Erickson; J Kyte
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.